Ploypetch S.Jaresitthikunchai J.Phaonakrop N.Sakcamduang W.Manee-in S.Suriyaphol P.Roytrakul S.Suriyaphol G.Mahidol University2023-06-182023-06-182022-12-01Scientific Reports Vol.12 No.1 (2022)https://repository.li.mahidol.ac.th/handle/20.500.14594/86362Tumors frequently found in dogs include canine oral tumors, either cancerous or noncancerous. The bloodstream is an important route for tumor metastasis, particularly for late-stage oral melanoma (LOM) and late-stage oral squamous cell carcinoma (LOSCC). The present study aimed to investigate serum peptidome-based biomarkers of dogs with early-stage oral melanoma, LOM, LOSCC, benign oral tumors, chronic periodontitis and healthy controls, using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and liquid chromatography tandem mass spectrometry. A principal component analysis plot showed distinct clusters among all groups. Four peptides were identified, including peptidyl-prolyl cis-trans isomerase FKBP4 isoform X2 (FKBP4), steroid hormone receptor ERR1 (ESRRA or ERRA), immunoglobulin superfamily member 10 (IGSF10) and ATP-binding cassette subfamily B member 5 (ABCB5). FKBP4, ESRRA and ABCB5 were found to be overexpressed in both LOM and LOSCC, whereas IGSF10 expression was markedly increased in LOSCC only. These four proteins also played a crucial role in numerous pathways of cancer metastasis and showed a strong relationship with chemotherapy drugs. In conclusion, this study showed rapid screening of canine oral tumors using serum and MALDI-TOF MS. In addition, potential serum peptidome-based biomarker candidates for LOM and LOSCC were identified.MultidisciplinaryUtilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumorsArticleSCOPUS10.1038/s41598-022-26132-y2-s2.0-851442749872045232236517562